NYSE:QGENLife Sciences
Qiagen (QGEN) Valuation Check As New QuantiFERON TB Data Reinforces Leadership In Tuberculosis Detection
Qiagen (QGEN) is back in focus after newly published clinical and health economic data supported its QuantiFERON-TB Gold Plus test for tuberculosis detection, together with an upcoming global QuantiFERON World TB Day online event.
See our latest analysis for Qiagen.
Despite the renewed attention on QuantiFERON, Qiagen’s 30-day share price return of 19.64% and year to date share price return of 17.87% both point to fading near term momentum. The 5 year total shareholder return of 20.51%...